Product
CB-839 (telaglenastat)
PHARMACEUTICAL
byCornerstone Pharmaceuticals
United States (US)
ABOUT THE PRODUCT
Another drug candidate in preclinical development, also focused on altered cancer metabolism.
Information is owner-confirmed
Last updated 3 weeks ago
Price range